Table 2.
Demographic and clinical characteristics of the study groups: day 6.
| Variables | Melatonin group Day 6 |
Control group Day 6 |
P-value Day 6 |
|---|---|---|---|
| WBC (×1000/μL) | 12.44 ± 5.17 | 13.68 ± 6.29 | 0.491 |
| Neutrophil (×1000/μL) | 12,840 ± 9640 | 11,980 ± 5670 | 0.770 |
| Lymph (×1000/μL) | 910 ± 410 | 1320 ± 950 | 0.077 |
| Neutrophil/lymph | 15.86 ± 11.70 | 11.97 ± 5.44 | 0.267 |
| Platelet (×1000/μL) | 195.73 ± 87.13 | 149.62 ± 68.03 | 0.048 |
| Urea (mg/dL) | 86.73 ± 68.67 | 105.13 ± 68.27 | 0.337 |
| Cr (mg/dL) | 1.14 ± 0.46 | 1.25 ± 0.54 | 0.401 |
| ALT (U/L) | 44.30 ± 30.33 | 51.88 ± 53.93 | 0.559 |
| AST (U/L) | 96.03 ± 188.76 | 70.10 ± 118.83 | 0.598 |
| CRP (mg/L) | 47.28 ± 38.86 | 75.52 ± 48.02 | 0.042 |
| ESR (mm/h) | 85.57 ± 38.35 | 60.71 ± 29.28 | 0.163 |
WBC: white blood cells, Lymph: lymphocytes, Cr: serum creatinine, ALT: alanine aminotransferase, AST: aspartate aminotransferase, CRP: C-reactive protein, ESR: erythrocyte sedimentation rate.